Tolera granted Orphan... Home About Us Product Pipeline News Contact Us PRESS RELEASE Tolera Therapeutics granted Orphan Drug Designation for organ transplant rejection drug... Kalamazoo, Michigan, Tuesday, April 7, 2009 Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for its initial lead... industry pipeline offers few solutions to advance patient care and meet this critical need. The Orphan Drug Act was enacted to allow the FDA to grant a product special orphan status...

Announces closing of Series B-3 funding Tolera Therapeutics Announces Appointment of Linda C. Hogan, VP of Business Development Tolera Therapeutics granted Orphan Drug Designation... for treatment of Type 1 diabetes mellitus Tolera granted Orphan Drug Designation for organ transplant rejection drug See Related Articles... 2011 Tolera Therapeutics, Inc. 350 E...

transplant and ultimately as a preventative therapeutic to induce tolerance of new organs and tissue.In 2009, TOL101 received Orphan Drug designation from the US Food and Drug...

medical need.In 2010, TOL101 received Orphan Drug Designation from the US Food and Drug Administration for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM...